Restless legs syndrome is one of those conditions that sounds minor until you have it: an overwhelming urge to move your legs, usually at night, that wrecks sleep. New research suggests low-dose cannabis may help ease it, and while the results are genuinely promising, the science is still early.
What the study found
Researchers at Universidad Europea de Madrid, publishing in the Journal of Neurology, tested a cannabis product containing roughly 2.7mg THC and 2.5mg CBD, a notably low dose. Among patients with multiple sclerosis and associated idiopathic RLS, the product reduced symptom severity, with improvements showing up at 1 and 3 months and holding steady at 1 year for those who continued treatment.
Why it might work
Researchers point to two mechanisms: THC's muscle-relaxant effect and CBD's potential to support sleep, which is exactly the domain RLS disrupts. It echoes what we have seen in related conditions, including cannabis for MS symptoms, where the signal is real but the research still needs to catch up.
The honest caveats
This is one study in a specific population, and the broader evidence base for cannabis and RLS remains limited and mixed. Larger, placebo-controlled trials are underway, including at Sunnybrook Health Sciences Centre and the University of Colorado, to test whether the benefits hold up under stricter conditions. Some trials even exclude people with serious liver disease, a reminder that cannabinoids are not risk-free for everyone.
The takeaway is measured optimism: a low-dose, balanced THC-to-CBD approach shows promise for a stubborn condition, but the case is not closed. This article is informational and not medical advice. If you are considering cannabis for restless legs or any health condition, talk with a qualified healthcare provider first. For adults 21 and over.